蛋白质结晶市场－全球产业规模、份额、趋势、机会及预测（依产品、技术、最终用户、地区及竞争格局划分，2021-2031年）

全球蛋白质结晶市场预计将从 2025 年的 22.1 亿美元成长到 2031 年的 36.9 亿美元，复合年增长率为 8.92%。

这项技术主要透过X射线晶体衍射，将蛋白质分子排列成有序的重复晶格，以实现结构解析。该领域的发展主要得益于药物研发中基于结构的药物设计方法的日益普及，以及对复杂生物标的高分辨率模型的迫切需求。这导致了高通量筛检所需的特定试剂和自动化液体处理系统的持续需求。 RCSB蛋白质资料库的数据凸显了这项技术的广泛应用，报告显示，到2024年，将有9,200个生物大分子结构透过X射线衍射法解析出来。

儘管呈现正面趋势，但由于膜蛋白和不稳定大分子复合物结晶的高失败率，市场仍面临许多挑战。晶体形成过程中固有的不确定性常常导致计划週期延长和研究成本增加。这些经济和技术障碍阻碍了小规模、资源匮乏的实验室广泛采用结晶工作流程，从而限制了该领域的市场扩张。

市场驱动因素

製药和生物技术领域研发投入的不断增长是蛋白质结晶市场的主要驱动力，推动了先进设备和高纯度试剂的购买。随着药物研发人员专注于发现新的治疗标靶，结构生物学部门的经费投入也不断增加，以支持解析大分子结构的复杂过程。这一趋势在主要行业领导者的预算中显而易见；例如，默克公司在2024年2月报告称，其2023财年的年度研发支出将达到305亿美元。如此巨额的投资确保了结晶设施的持续运行，从而能够分析日益增多的生物候选药物。此外，美国食品药物管理局（FDA）药物评估与研究中心在2024年核准了55种新型治疗药物，也印证了这个成长趋势。

同时，自动化和高通量筛检技术的突破正在透过最大限度地减少人为误差和最佳化实验密度来提升结晶效率。将人工智慧融入液体处理系统能够精确预测结晶条件，这是基于结构的药物设计的关键要素。这些创新对于检验计算模型至关重要，因为物理晶体仍然是确认原子间相互作用的最终标准。为了凸显这种协同效应，Google在2024年5月宣布，其AlphaFold 3模型预测蛋白质-配体交互作用的准确率比传统方法高出50%。这使得检验这些预测结果需要建立稳健的实体工作流程。因此，自动化硬体和计算工具的结合正在降低复杂靶点的分析门槛，并扩大市场覆盖范围。

市场挑战

膜蛋白和不稳定大分子复合物结晶的高失败率导致结构测定效率显着降低，并严重阻碍了全球蛋白质结晶市场的发展。由于这些生物标靶本身难以稳定，研究人员常常经历反覆的实验失败，导致计划週期延长，并过度消耗昂贵的试剂。这种不可预测性降低了结​​晶工作流程的效率，并直接阻碍了整个产业为提高药物设计速度和自动化程度所做的努力。

此外，这些失败带来的经济负担限制了小规模研究机构的市场渗透。高昂的营运成本使得预算有限的实验室无力购买必要的自动化液体处理系统，导致先进的结晶技术仅限于资金雄厚的机构使用。美国药品研究与製造商协会 (PhRMA) 的一份报告凸显了这一成本障碍的巨大影响，该报告指出，到 2024 年，其成员公司每年将在研发方面投入约 1000 亿美元。如此庞大的资金需求，部分源自于技术效率低下，限制了结晶解决方案的潜在基本客群，并阻碍了其在大型製药企业以外的广泛应用。

市场趋势

串行飞秒晶体学（SFX）的兴起正在革新结构生物学，使人们能够在室温下观察大分子动力学，这是传统低温冷却技术无法实现的。该技术利用X射线自由电子雷射发射超高亮度脉衝，在辐射损伤发生之前捕获衍射数据，使研究人员能够记录生物过程的分子级动力学。这项技术对于即时理解快速酶反应和配体结合至关重要，并推动了市场对兼容高强度光源的专用样品输送系统的需求。该领域的一项重大进展是，美国能源局SLAC国家加速器实验室于2024年9月宣布LCLS-II升级工程已完成，使该设施每秒可产生高达一百万个X射线脉衝，比之前的极限提高了8000倍。

同时，随着製药公司寻求降低药物研发早期阶段的固定基础设施成本，外包给受託研究机构（CRO）的趋势日益明显。药物研发人员不再维护成本高成本的内部结晶设施，而是越来越依赖外部合作伙伴的工业级平台来管理复杂的筛检研究和结构解析。这种策略转变使生物製药公司能够将固定资本支出转化为可变营运成本，同时获得广泛的技术专长，而无需承担维护设施的额外费用。无锡艾普泰克2024财年（截至2024年3月）的年度报告印证了这一转变，该报告显示，其提供全面早期药物筛检服务的无锡生物事业部营收达到25.5亿元人民币。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球蛋白质结晶市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（设备（液体处理设备、晶体成像设备）、耗材（试剂、试剂盒/筛检、微孔盘等）、软体和服务）
  • 透过技术手段（X射线晶体学、冷冻电镜、核磁共振波谱学等）
  • 依最终用户（製药/生技公司、学术研究机构）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美蛋白质结晶市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲蛋白质结晶市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区蛋白质结晶市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲蛋白质结晶市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲蛋白质结晶市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球蛋白质结晶市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Rigaku Corporation
• Mettler-Toledo International Inc.
• Corning Incorporated
• Greiner Bio-One International GmbH
• HAMPTON RESEARCH CORP
• Jena Bioscience GmbH
• Bruker Corporation
• Creative Proteomics
• Molecular Dimensions Limited

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Protein Crystallization Market is projected to expand from USD 2.21 Billion in 2025 to USD 3.69 Billion by 2031, reflecting a compound annual growth rate of 8.92%. This technical process involves organizing protein molecules into ordered, repeating lattices to facilitate structural determination, primarily through X-ray crystallography. Growth in this sector is largely fueled by the rising adoption of structure-based drug design within pharmaceutical research and the essential need for high-resolution models of complex biological targets. Consequently, there is sustained demand for the specific reagents and automated liquid handling systems required for high-throughput screening. Data from the RCSB Protein Data Bank highlights the prevalence of this technique, noting that 9,200 biological macromolecule structures were solved using X-ray diffraction methods in 2024.

Despite this positive trajectory, the market faces significant hurdles due to the high failure rates associated with crystallizing membrane proteins and unstable macromolecular complexes. The inherent unpredictability of crystal formation frequently results in prolonged project timelines and increased research costs. These financial and technical barriers hinder the widespread adoption of crystallization workflows in smaller laboratories that lack extensive resources, effectively limiting market expansion in those sectors.

Market Driver

Increased research and development spending within the pharmaceutical and biotechnology sectors serves as a fundamental catalyst for the protein crystallization market, facilitating the acquisition of sophisticated instrumentation and high-purity reagents. As drug developers concentrate on discovering novel therapeutic targets, financial allocations to structural biology departments have grown to support the intricate process of elucidating macromolecular structures. This trend is evident in the budgets of major industry leaders; for instance, Merck & Co. reported in February 2024 that its full-year research and development expenses for 2023 reached $30.5 billion. Such substantial investment ensures the continuous operation of crystallization facilities needed to analyze the growing influx of biological candidates, a volume reflected by the FDA's Center for Drug Evaluation and Research approval of 55 novel therapeutics in 2024.

In parallel, technological breakthroughs in automation and high-throughput screening are transforming crystallization efficiency by minimizing human error and optimizing experimental density. The incorporation of artificial intelligence into liquid handling systems enables the accurate prediction of crystallization conditions, a vital component of structure-based drug design. These innovations are essential for validating computational models, as physical crystals remain the definitive standard for confirming atomic interactions. Highlighting this synergy, Google announced in May 2024 that its AlphaFold 3 model predicts protein-ligand interactions with 50% greater accuracy than conventional methods, creating a need for robust physical workflows to verify these predictions. Thus, the combination of automated hardware and computational tools is reducing barriers for analyzing complex targets and broadening the market's scope.

Market Challenge

The Global Protein Crystallization Market is significantly impeded by the high attrition rates encountered when crystallizing membrane proteins and unstable macromolecular complexes, which introduce considerable inefficiency into structural determination efforts. Since these biological targets are inherently difficult to stabilize, researchers frequently experience repeated experimental failures that lead to extended project timelines and the excessive consumption of expensive reagents. This unpredictability diminishes the throughput of crystallization workflows, directly undermining the industry's broader push for speed and automation in drug design initiatives.

Moreover, the financial strain caused by these failures restricts market penetration into smaller research segments. High operational costs prevent laboratories with limited budgets from acquiring necessary automated liquid handling systems, effectively restricting advanced crystallization capabilities to well-funded institutions. The magnitude of this cost barrier is illustrated by the Pharmaceutical Research and Manufacturers of America (PhRMA), which reported in 2024 that member companies invested approximately $100 billion in annual research and development. These immense capital requirements, driven in part by technical inefficiencies, limit the potential customer base for crystallization solutions and stall broader adoption outside of major pharmaceutical companies.

Market Trends

The rise of Serial Femtosecond Crystallography (SFX) is revolutionizing structural biology by allowing the visualization of macromolecular dynamics at room temperature, a feat not possible with standard cryo-cooled techniques. By utilizing X-ray free-electron lasers to emit ultra-bright pulses, this method captures diffraction data before radiation damage occurs, effectively enabling researchers to record molecular movies of biological processes. This capability is vital for understanding rapid enzymatic reactions and ligand binding in real time, driving the market toward specialized sample delivery systems that support high-intensity light sources. A key development in this area was announced by the Department of Energy's SLAC National Accelerator Laboratory in September 2024, revealing that the completed LCLS-II upgrade now allows the facility to generate up to one million X-ray pulses per second, an 8,000-fold increase over prior limits.

Simultaneously, there is a distinct trend toward outsourcing to Contract Research Organizations as pharmaceutical companies aim to minimize fixed infrastructure costs linked to early-stage discovery. Instead of upholding costly internal crystallization facilities, drug developers are increasingly relying on the industrial-scale platforms of external partners to manage complex screening campaigns and structural elucidation. This strategic shift enables biopharmaceutical firms to transform fixed capital expenditures into variable operational costs while gaining access to extensive technical expertise without the overhead of equipment maintenance. Evidence of this shift is found in WuXi AppTec's March 2024 annual report, which noted that revenue for its WuXi Biology segment, offering comprehensive early discovery screening services, reached RMB 2.55 billion.

Key Market Players

• Rigaku Corporation
• Mettler-Toledo International Inc.
• Corning Incorporated
• Greiner Bio-One International GmbH
• HAMPTON RESEARCH CORP
• Jena Bioscience GmbH
• Bruker Corporation
• Creative Proteomics
• Molecular Dimensions Limited

Report Scope

In this report, the Global Protein Crystallization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Crystallization Market, By Product

• Instruments (Liquid Handling Instruments, Crystal Imaging Instruments)
• Consumables (Reagents & Kits/Screens, Micro Plates, Others)
• Software & Services

Protein Crystallization Market, By Technology

• X-ray Crystallography
• Cryo-electron Microscopy
• NMR Spectroscopy
• Others

Protein Crystallization Market, By End User

• Pharmaceutical And Biotechnology Companies
• Academic Research Institutes

Protein Crystallization Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Crystallization Market.

Available Customizations:

Global Protein Crystallization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Crystallization Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments( Liquid Handling Instruments, Crystal Imaging Instruments), Consumables( Reagents & Kits/Screens, Micro Plates, Others), Software & Services)
  • 5.2.2. By Technology (X-ray Crystallography, Cryo-electron Microscopy, NMR Spectroscopy, Others)
  • 5.2.3. By End User (Pharmaceutical And Biotechnology Companies, Academic Research Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Protein Crystallization Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein Crystallization Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Protein Crystallization Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Protein Crystallization Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End User

7. Europe Protein Crystallization Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Protein Crystallization Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End User
  • 7.3.2. France Protein Crystallization Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Protein Crystallization Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Protein Crystallization Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Protein Crystallization Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End User

8. Asia Pacific Protein Crystallization Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Protein Crystallization Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End User
  • 8.3.2. India Protein Crystallization Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Protein Crystallization Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Protein Crystallization Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Protein Crystallization Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By End User

9. Middle East & Africa Protein Crystallization Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Protein Crystallization Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Protein Crystallization Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Protein Crystallization Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End User

10. South America Protein Crystallization Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Protein Crystallization Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Protein Crystallization Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Protein Crystallization Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Protein Crystallization Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Rigaku Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Mettler-Toledo International Inc.
• 15.3. Corning Incorporated
• 15.4. Greiner Bio-One International GmbH
• 15.5. HAMPTON RESEARCH CORP
• 15.6. Jena Bioscience GmbH
• 15.7. Bruker Corporation
• 15.8. Creative Proteomics
• 15.9. Molecular Dimensions Limited

16. Strategic Recommendations

17. About Us & Disclaimer